{"entity":{"type":"insider","cik":"0001517780","url":"/insider/0001517780","json_url":"/insider/0001517780.json","name":"MORNEAU MICHAEL","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2013-05-16","last":"2018-05-31","span_basis":"filed_date"},"name_variants":[{"name":"MORNEAU MICHAEL","source":"filing","n_filings":3,"first_seen":"2013-05-16","last_seen":"2018-05-31"}],"transactions":[{"id":6706384,"accession":"0001209191-18-034494","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-034494","line_url":"/filing/0001209191-18-034494#line-1","is_derivative":false,"issuer_cik":"0001517780","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001517780","owner_cik":"0001517780","owner_name":"MORNEAU MICHAEL","owner_display_name":"MORNEAU MICHAEL","owner_url":"/insider/0001517780","role":"Officer (VP, Finance and Administration)","role_mark":"O","role_mark_label":"Officer (VP, Finance and Administration)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Finance and Administration","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21551.0,"shares_display":"21,551","price_per_share":9.25,"price_display":"9.25","price_state":"stated","total_value":199346.75,"total_display":"199,346.75","total_whole":"199,347","shares_owned_after":94035.0,"shares_owned_after_display":"94,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-31","filed_date":"2018-05-31","scope":"insider"},{"id":4505164,"accession":"0001209191-13-036533","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-036533","line_url":"/filing/0001209191-13-036533#line-2","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001517780","owner_name":"MORNEAU MICHAEL","owner_display_name":"MORNEAU MICHAEL","owner_url":"/insider/0001517780","role":"Officer (VP Finance & CAO)","role_mark":"O","role_mark_label":"Officer (VP Finance & CAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Finance & CAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":9.75,"price_display":"9.75","price_state":"stated","total_value":195000.0,"total_display":"195,000.00","total_whole":"195,000","shares_owned_after":12545.0,"shares_owned_after_display":"12,545","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-11","filed_date":"2013-07-12","scope":"insider"},{"id":5398843,"accession":"0001209191-13-026751","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-026751","line_url":"/filing/0001209191-13-026751#line-2","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001517780","owner_name":"MORNEAU MICHAEL","owner_display_name":"MORNEAU MICHAEL","owner_url":"/insider/0001517780","role":"Officer (VP Finance & CAO)","role_mark":"O","role_mark_label":"Officer (VP Finance & CAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Finance & CAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":7.75,"price_display":"7.75","price_state":"stated","total_value":155000.0,"total_display":"155,000.00","total_whole":"155,000","shares_owned_after":10635.0,"shares_owned_after_display":"10,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-14","filed_date":"2013-05-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001607678","name":"Viking Therapeutics, Inc.","url":"/issuer/0001607678","role":"Officer (VP, Finance and Administration)","n_filings":1,"first_seen":"2018-05-31","last_seen":"2018-05-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001356857","name":"Trius Therapeutics Inc","url":"/issuer/0001356857","role":"Officer (VP Finance & CAO)","n_filings":2,"first_seen":"2013-05-16","last_seen":"2013-07-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001517780","retrieved_at":"2026-08-27T15:43:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}